Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine
about
Kynurenine 3-Monooxygenase: An Influential Mediator of NeuropathologyContinuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult ratsBehavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.Potential role of the combination of galantamine and memantine to improve cognition in schizophreniaA systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of ratsThe effects of postnatal alcohol exposure and galantamine on the context pre-exposure facilitation effect and acetylcholine efflux using in vivo microdialysis.Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophreniaAltered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamineElevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantinePerinatal complications and schizophrenia: involvement of the immune system.Cytokines and the neurodevelopmental basis of mental illnessThe effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia.Targeting of NMDA receptors in new treatments for schizophrenia.Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid.Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood.Probiotic, Prebiotic, and Brain Development.Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood.Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress.Restraint Stress during Pregnancy Rapidly Raises Kynurenic Acid Levels in Mouse Placenta and Fetal Brain.Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
P2860
Q26782867-BCF79103-5E60-4FE2-856C-F1FB9E1F7B95Q30408061-77CC9626-92BB-4452-96D2-7A3B4F6E9EC7Q30419650-6D5E6F43-9C15-42C8-8356-D7E2E6507FCAQ33572850-E4489D4E-C555-4D44-B2ED-695FE50F5B8CQ33905343-A1A92545-574A-4B66-AD9B-0EFED30F3ADFQ35213516-F51D33B3-F8F6-494A-84BB-D6641E57044AQ35554418-A07E1D56-C07E-4F7A-899A-F6A9711CC3DCQ35892576-15056C69-1C65-4C7F-9246-DE917C089D15Q36273903-B4EA9093-1F45-4360-91ED-BC09205772A4Q36515238-28DC216C-F146-440B-A180-4333F44E9927Q36778677-DCDCA662-ACA7-4081-97CF-8D05577E318BQ36952179-AA9A3E5B-5FDD-4DBC-B327-C15B307BBD73Q37232855-D582AE51-2DC7-4618-88B2-0AA27EFB471DQ37351984-E8A7CDE8-30F0-4C07-B40D-F21A2ABE08EDQ38223276-47D730F7-CFEC-4049-B178-74DEBD1A56CAQ38669116-2580979A-0749-45E3-87AF-F2DB0CF491ACQ38761405-567D2AB5-E959-4DFE-9508-98B551098980Q38809444-1BCAF649-4E43-452A-A3F2-1AA94E042ABFQ39130393-A0E2EBC6-7DFC-4BE5-95B4-41A7B9C69FB4Q39777451-9D718B02-D0EF-4181-A196-32D3F4A0A373Q43092673-CB580521-CF91-4F4F-A099-42D99AC8DB1AQ47114796-4BBF0A27-AF08-4668-B97C-0D430FC0D090Q47973666-2C2567BF-A01B-4D3B-8398-7547E33EAA7EQ48158678-C275D74A-B5EF-43F6-BE7A-7B5250D77046Q48302638-CBB07A67-82CE-4FA5-ADE1-6D30684A0FD3Q50331698-3D0B9FB0-42C9-461E-B731-B428A4B962E5
P2860
Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Early developmental elevations ...... lts: reversal with galantamine
@ast
Early developmental elevations ...... lts: reversal with galantamine
@en
type
label
Early developmental elevations ...... lts: reversal with galantamine
@ast
Early developmental elevations ...... lts: reversal with galantamine
@en
prefLabel
Early developmental elevations ...... lts: reversal with galantamine
@ast
Early developmental elevations ...... lts: reversal with galantamine
@en
P2093
P2860
P1433
P1476
Early developmental elevations ...... lts: reversal with galantamine
@en
P2093
A Pocivavsek
K S Alexander
M L Pershing
R Schwarcz
P2860
P356
10.1016/J.NEUROSCIENCE.2013.01.063
P407
P577
2013-02-06T00:00:00Z